William B. Stilley III - 23 May 2023 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Director
Signature
/s/ William B. Stilley, III
Issuer symbol
ADIL
Transactions as of
23 May 2023
Net transactions value
$0
Form type
4
Filing time
25 May 2023, 16:47:59 UTC
Previous filing
03 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADIL Common Stock Award $0 +240,800 +24% $0.000000 1,261,779 23 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 23 May 2023 Common Stock 50,000 $0.3025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023.